Benign Prostatic Hyperplasia Devices Market


Posted January 8, 2021 by jivankumar

Benign prostatic hyperplasia market is also called as BPH which is a condition in men where the prostate gland is enlarged and is not cancerous.

 
Benign prostatic hyperplasia market is also called as BPH which is a condition in men where the prostate gland is enlarged and is not cancerous. Benign prostatic hyperplasia is also known as benign prostatic obstruction or benign prostatic hypertrophy. The prostate usually goes through 2 main growth stages as a man ages. The first stage happens early in puberty, when prostate doubles in size, whereas the second phase of growth occurs around the age of 25 and continues through most of a man’s life. BPH often happens with the second stage of growth. Middle East & Africa benign prostatic hyperplasia devices market is expected to reach at a CAGR of 10.5% in the forecast period of 2019 to 2026.
Middle East & Africa benign prostatic hyperplasia devices market is segmented based on procedure type and end user. Middle East & Africa Benign Prostatic Hyperplasia Devices Market By Procedure Type (Transurethral Resection of the Prostate (TURP), Prostatic Urethral Lift, Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Prostatic Stenting/Implants, Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers), Country (South Africa, Rest of Middle East & Africa) – Industry Trends and Forecast to 2026.

Download full sample report of Benign prostatic hyperplasia devices market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-africa-benign-prostatic-hyperplasia-devices-market

On the basis of procedure type, the market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift, prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others. Laser surgery is sub-segmented into holmium lasers, green light laser/PVP and thulium laser based devices. The others segment is sub-segmented into water-induced thermotherapy, high-intensity frequency ultrasound (HIFU), prostatic artery embolization (PAE) and others. Prostatectomy segment is growing at the highest CAGR of 11.6% in the forecast period of 2019 to 2026.
In October 2015, Lumenis launched pulse laser systems which can be used for the prostate and stones treatment. The Pulse 50H laser and Pulse 100H systems is designed for the treatment of benign prostatic hyperplasia (BPH) and stones. The additions of pulse products show a key development to current urological solutions. This addition will help in increasing the company’s product line.
On the basis of end user, the market is segmented into hospitals and clinics and ambulatory surgical centers. Hospitals and clinics are growing at the highest CAGR of 10.7% in the forecast period of 2019 to 2026.
In February 2019, Teleflex Incorporated’s subsidiary Neotract, Inc (U.S.) expanded its UroLift business. Humana which is a one of the nation’s largest private health insurers is now providing insurance coverage for the UroLift system. This will help the company in grasping more customers.
Competitive Analysis: Middle East & Africa Benign Prostatic Hyperplasia Devices Market
Some of the major players operating in this market are KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp, LISA Laser Products GmbH, Medifocus, Inc., Coloplast Corp, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, Biolitec AG and others.
Product Launch:
In January 2019, Boston Scientific Corporation has launched Rezūm water vapor therapy and the randomized clinical trial results shows that it offers long-lasting results in minimally invasive treatment for benign prostatic hyperplasia (BPH). This product launch will increase the company’s product line.
In March 2017, Biolitec has launched XCAVATOR laser fiber which can be used in the benign prostatic hyperplasia (BPH) treatment. The laser fiber can remove tissue on the prostate at a rate of 3 to 4 grams per minute. This new technological advanced product will offer the urologist an attractive option for their surgery and this will help to increase the company’s product line.
In January 2016, Medifocus Inc. announced the engagement of the Tanaka Kapec Design Group, Inc. as a lead designer of the next generation Prolieve Thermodilatation System. This combinational therapy helped in offering both immediate and the long term relief in the BPH related symptoms.
In October 2015, Lumenis launched pulse laser systems which can be used for the prostate and stones treatment. The Pulse 50H laser and Pulse 100H systems is designed for the treatment of benign prostatic hyperplasia (BPH) and stones. The additions of pulse products show a key development to current urological solutions. This addition will help to increase the company’s product line.
In September 2014, Lisa Laser USA has launched RevoLix 200watt for the BPH treatment. It uses the wavelength of 2013 nm, which targets the water in the tissue, providing superior vaporization, cutting and hemostasis of the prostate. The company will be benefitted from the launch as the product launch will increase the company’s product portfolio.
In 2011, Urologix signed an exclusive worldwide license for Prostiva RF Therapy System which is used for BPH treatment from Medtronic, Inc. This helped in expanding the product portfolio of the company.

Want any help speak to our analyst @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=middle-east-africa-benign-prostatic-hyperplasia-devices-market

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-africa-benign-prostatic-hyperplasia-devices-market

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

Browse Related Reports @
Intrapartum Monitoring Devices Market
N95 Mask Market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By dbmr
Phone 07498270816
Business Address At post Dabha
Country India
Categories Blogging
Last Updated January 8, 2021